Zobrazeno 1 - 10
of 233
pro vyhledávání: '"G. Morgan Jones"'
Autor:
L. Goodwin Burgess, Nitin Goyal, G. Morgan Jones, Yasser Khorchid, Ali Kerro, Kristina Chapple, Georgios Tsivgoulis, Andrei V. Alexandrov, Jason J. Chang
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 7, Iss 8 (2018)
BackgroundWe sought to assess the risk of acute kidney injury (AKI) and mortality associated with intensive systolic blood pressure reduction in acute intracerebral hemorrhage. Methods and ResultsPatients with acute intracerebral hemorrhage had spont
Externí odkaz:
https://doaj.org/article/95f60f5bde1a46ff90883bc2de04fcaf
Autor:
Brittany M. Kasturiarachi, Rashi Krishnan, Diana L. Alsbrook, Brittany Hudson, Hallie Kelly, Caitlin E. Moran, Khalid Alsherbini, G. Morgan Jones
Publikováno v:
Neurohospitalist
Background Intravenous (IV) levetiracetam (LEV) is an antiseizure medication traditionally given as an intermittent infusion to mitigate potential adverse effects given its acidic formulation. The process of compounding may lead to delays in treating
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c523c4eb36d737d105f399cd1b2259c
https://pubmed.ncbi.nlm.nih.gov/35419138
https://pubmed.ncbi.nlm.nih.gov/35419138
Autor:
Kerry Mohrien, Lauren A. Kimmons, Jacob Marler, Joseph E. Vandigo, Rachel Howland, G. Morgan Jones
Publikováno v:
Hosp Pharm
Purpose: Septic patients are at risk for hypotension, and this risk may increase during rapid sequence intubation (RSI). Sedatives such as propofol must be used carefully due to its ability to reduce vascular sympathetic tone. Since the safety of pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98b67fb35235d2c53cef7f3c00fe90fe
https://doi.org/10.1177/00185787211029547
https://doi.org/10.1177/00185787211029547
Autor:
Sterling C Torian, G Morgan Jones
Publikováno v:
The Neurohospitalist. :194187442311669
Lacosamide (LCM) is an antiseizure medication used to manage status epilepticus (SE). Previous retrospective analyses have demonstrated safety and efficiency in intravenous push (IVP) administration at 80 mg per minute. Quick administration can be ac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::db8b07c40565b2f2ad4ccfee3ced18dc
https://doi.org/10.1177/19418744231166984
https://doi.org/10.1177/19418744231166984
Publikováno v:
Journal of Critical Care. 61:133-137
Norepinephrine (NE) is recommended first-line for treatment of septic shock, partly due to its intrinsically low effect on heart rate. While dysrhythmias secondary to NE are still reported, factors associated with development of this adverse effect h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2258e7fcd7b03ba3e17721cb69b1ab91
https://doi.org/10.1016/j.jcrc.2020.10.023
https://doi.org/10.1016/j.jcrc.2020.10.023
Autor:
Nicholas G. Panos, Aaron M. Cook, Sayona John, G. Morgan Jones, Hallie Kelly, Richard K. Choi, Nirali Kalaria, Jamie M. Rosini, Mathew Jones, Mohammed Rehman, Philip M. Ross, Benjamin Motley, Samantha Delibert, Benjamin P. George, Charles M Andrews, Ron R Neyens, Ryan Martin, Kendra J. Schomer, Michael J. Armahizer, Mehrnaz Pajoumand, Casey C. May, Keaton S. Smetana, Tamara Strohm, Christian Hamm, Laurel Jakubowski, Shaun P. Keegan, Vasisht Srinivasan, Christopher J. Burdick, Omar J. Martinez, Farhad Bahrassa, Scott T. May, K. Ashley Sowers, Eugene I. Lin, Deidre J. Rohaley, Jason Mackey, Lori L. Wetmore, Christine Frick, Meena Thatikunta, Lindsay Urben, Abdalla A. Ammar, Kent A. Owusu, Keith Nguyen, Michael J. Erdman, Brian W. Gilbert, Joshua M. DeMott, Gary D. Peksa, Philip E. Tobias, Ivan Da Silva, Leana N. Mahmoud, Bethany Sheahan, Aimee Gowler Gennaro, Michael A. Pizzi, Gretchen M. Brophy, Dennis J. Rivet, Micheal Strein, Kristine Arandela, Van Hellerslia, Meghan M. Caylor
Publikováno v:
Circulation. 141:1681-1689
Background: Since the approval of the oral factor Xa inhibitors, there have been concerns regarding the ability to neutralize their anticoagulant effects after intracranial hemorrhage (ICH). Multiple guidelines suggest using prothrombin complex conce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31ef9ef4de6d21466134faa9c42c1a93
https://doi.org/10.1161/circulationaha.120.045769
https://doi.org/10.1161/circulationaha.120.045769
Autor:
Diane McLaughlin, Lori Shutter, Karen G. Hirsch, Lara Zimmermann, Sheri Tokumaru, Christopher Zacko, Sophie Samuel, Alexander Papangelou, Patrick Mailloux, Chitra Venkatasubramanian, G. Morgan Jones, Aaron M. Cook, Gregory W.J. Hawryluk
Publikováno v:
Neurocritical Care
Neurocritical care, vol 32, iss 3
Neurocritical care, vol 32, iss 3
Background Acute treatment of cerebral edema and elevated intracranial pressure is a common issue in patients with neurological injury. Practical recommendations regarding selection and monitoring of therapies for initial management of cerebral edema
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78da91701cc22dcaea4f970448c3a149
http://europepmc.org/articles/PMC7272487
http://europepmc.org/articles/PMC7272487
Publikováno v:
Critical Care Nursing Quarterly. 43:109-121
Elevated blood pressure is common in patients with acute ischemic stroke. While this may occur secondary to the body's own response to preserve cerebral blood flow, elevated blood pressure may also increase the risk of hemorrhagic transformation. Cur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::905735435c927eec035f47104336e586
https://doi.org/10.1097/cnq.0000000000000297
https://doi.org/10.1097/cnq.0000000000000297
Publikováno v:
Neurohospitalist
Background and Purpose: Current guidelines suggest that 3-factor prothrombin complex concentrate is a possible alternative to 4-factor products for the emergent reversal of bleeding secondary to warfarin. While multiple observational studies have eva
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e24c4e1cbd8f068e08bbc1e7d677cf0
https://doi.org/10.1177/1941874420905755
https://doi.org/10.1177/1941874420905755
Publikováno v:
Critical care nursing quarterly. 45(2)
Severe bleeding remains the most significant adverse effect associated with both warfarin and the direct oral anticoagulant agents. Due to the life-threatening nature of these bleeds, knowledge and understanding of agents that are able to rapidly ove
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6d7297cffe57f0ba25c08282a00d41c
https://pubmed.ncbi.nlm.nih.gov/35212656
https://pubmed.ncbi.nlm.nih.gov/35212656